ArticleBMC ophthalmology2026
Comprehensive analysis of RS1 gene mutations and clinical manifestations in nine unrelated X-linked retinoschisis (XLRS) Chinese families.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeX-linked retinoschisis (XLRS) is an X-linked recessive (XLR) inherited retinal disease. Accurate diagnosis of XLRS is difficult because of its diverse clinical presentations and genetic heterogeneity. However, targeted exome sequencing (TES) can aid in making an accurate diagnosis, especially for patients with no typical pathologic symptoms. The aim of this study was to identify pathogenic mutations in patients from nine nonconsanguineous XLRS families via genetic screening and investigate the associations between gene mutations and clinical manifestations.
methodsNine unrelated Chinese XLRS patients and their family members were recruited for genetic screening. Demographic characteristics and ocular data, including visual acuity, intraocular pressure, and ocular manifestations, were collected from all patients. Gene mutations were identified using TES and genetic analysis. The results were validated in available family members by Sanger sequencing and co-segregation analysis.
resultsWe successfully identified seven RS1 gene mutations in nine nonconsanguineous Chinese patients with binocular retinoschisis. Of these, one mutation (c.420_423delinsA) was a novel mutation, and the patient presented with binocular macular and peripheral retinoschisis. All patients were male, and female carriers had no clinical symptoms, which is consistent with an XLR inheritance pattern. RS1 mutations were concentrated in exons 4, 5 and 6, most mutations were missense mutations, all of which caused changes in the discoidin domains of retinoschisin 1 (RS1).
conclusionThis study reveals the importance of genetic screening in the clinical diagnosis of XLRS patients with different phenotypes and reports a novel RS1 gene mutation. Comprehensive analysis of the correlations between RS1 genotypes and clinical phenotypes can improve the accurate diagnosis of XLRS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.